Patient Characteristics
| Patient | 99mTc glucarate | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Primary tumor location | Age (y) | Sex | pN | Stage after surgery of primary tumor | Size (cm)* | Pathology | Primary lesion or local relapse | Regional node involvement |
| 1 | Oropharynx cancer | 55 | M | N0 | IV | 5.5 | MDEC | + | − |
| 2 | Supraglottic tumor | 46 | M | N2c | IVA | 3.2 | MDEC | + | + |
| 3 | Nasopharynx tumor | 61 | M | N0 | IV | 4.6 | Undifferentiated carcinoma | + | − |
| 4 | Larynx cancer | 62 | M | N0 | IV | 3.8 | WDEC | + | − |
| 5 | Glottic and supraglottic cancer | 80 | M | N0 | III | 1.8 | WDEC | + | − |
| 6 | Carcinoma of right retromolar trigone | 57 | M | N1 | IV | 6.2 | WDEC | + | + |
| 7 | Tonsil cancer | 55 | M | N1 | IVA | 3.8 | WDEC | + | + |
| 8 | Larynx cancer | 66 | M | N3 | IV | 3.7 | WDEC | + | + |
| 9 | Right inferior maxillary tumor | 67 | M | N0 | IV | 3.9 | WDEC | + | − |
| 10 | Right nasogenian fold tumor (postsurgery) | 65 | M | Local relapse? | IV | 4.8 | Sclerosant basocellular epithelioma | + | − |
| 11 | Oropharynx tumor | 50 | M | Local relapse? | IVA | 2.2 | PDEC | + | − |
↵* Greatest dimension.
MDEC = moderately differentiated epidermoid carcinoma; WDEC = well-differentiated epidermoid carcinoma; PDEC = poorly differentiated epidermoid carcinoma.